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Elimination of Pain Improves Specificity of Clinical Diagnostic
Criteria for Adult Chronic Rhinosinusitis
Scott D. Hirsch, BS; Evan R. Reiter, MD, FACS; Laurence J. DiNardo, MD, FACS;
Wen Wan, PhD; Theodore A. Schuman, MD
Objective: Determine whether the elimination of pain improves accuracy of clinical diagnostic criteria for adult chronic
rhinosinusitis.
Study Design: Retrospective cohort study.
Methods: History, symptoms, nasal endoscopy, and computed tomography (CT) results were analyzed for 1,186 adults
referred to an academic otolaryngology clinic with presumptive diagnosis of chronic rhinosinusitis. Clinical diagnosis was
rendered using the 1997 Rhinosinusitis Taskforce (RSTF) Guidelines and a modified version eliminating facial pain, ear pain,
dental pain, and headache.
Results: Four hundred seventy-nine subjects (40%) met inclusion criteria. Among subjects positive by RSTF guidelines,
45% lacked objective evidence of sinonasal inflammation by CT, 48% by endoscopy, and 34% by either modality. Applying
modified RSTF diagnostic criteria, 39% lacked sinonasal inflammation by CT, 38% by endoscopy, and 24% by either modality.
Using either abnormal CT or endoscopy as the reference standard, modified diagnostic criteria yielded a statistically signifi-
cant increase in specificity from 37.1% to 65.1%, with a nonsignificant decrease in sensitivity from 79.2% to 70.3%. Analysis
of comorbidities revealed temporomandibular joint disorder, chronic cervical pain, depression/anxiety, and psychiatric medica-
tion use to be negatively associated with objective inflammation on CT or endoscopy.
Conclusion: Clinical diagnostic criteria overestimate the prevalence of chronic rhinosinusitis. Removing facial pain, ear
pain, dental pain, and headache increased specificity without a concordant loss in sensitivity. Given the high prevalence of
sinusitis, improved clinical diagnostic criteria may assist primary care providers in more accurately predicting the presence
of inflammation, thereby reducing inappropriate antibiotic use or delayed referral for evaluation of primary headache
syndromes.
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INTRODUCTION
Rhinosinusitis is a highly prevalent disease resulting
in a considerable burden on the healthcare system. In a
2012 survey, 12% of U.S. adults reported being diagnosed
with rhinosinusitis in the last year,1 resulting in more
than 20 million annual diagnoses.2 A review of ambulato-
ry care data from 2006 to 2010 demonstrated that rhino-
sinusitis accounted for more antibiotic prescriptions than
any other condition,3 with $11 billion in direct healthcare
costs.1,2 Further studies have demonstrated a substantial
relationship between acute and chronic rhinosinusitis
(CRS) and decreased work productivity,4 absenteeism,5
and reduced quality of life, suggesting substantial addi-
tional indirect costs.6
Despite the sizeable impact of rhinosinusitis, consid-
erable variation in diagnosis and management exists
across medical specialties.7,8 The observed variation in
treatment of rhinosinusitis may be due to the fact that
gold-standard diagnostic criteria remain elusive, and
evaluation in the primary care setting does not have the
benefit of nasal endoscopy to gain objective evidence of
sinus disease. Furthermore, the correlation between
symptoms and objective findings is imperfect.9,10 The
prevalence of abnormal sinus computed tomography (CT)
in patients reporting symptoms of rhinosinusitis has been
reported to be only 65% to 80%.9,11–14 Numerous condi-
tions may mimic the presentation of rhinosinusitis,
including allergic and nonallergic rhinitis, as well as neu-
rologic disorders such as vascular, migraine, or cluster
headaches; trigeminal neuralgia; and atypical facial pain.
The 1997 Task Force on Rhinosinusitis (RSTF)
defined CRS as the presence of two or more major factors
or one major and two minor factors (see Table I) persist-
ing for at least 12 weeks.15 The 2016 International
Consensus Statement on Rhinosinusitis (ICOR) updated
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diagnostic criteria for CRS to consist of 12 weeks of at
least two of the following symptoms: nasal obstruction/
congestion, anterior/posterior nasal discharge, facial pain/
pressure/fullness, and decreased sense of smell. The 2016
guidelines also added the requirement for objective verifi-
cation of mucosal inflammation, polyps, and/or purulent
sinus drainage via CT or nasal endoscopy for definitive
diagnosis of CRS.16
Updated diagnostic criteria for CRS continue to
include pain as an indicator for sinusitis, although stud-
ies have demonstrated poor correlation between facial
pain or headache and objective evidence of paranasal
sinus inflammation. In rhinologic patients with radio-
graphically or endoscopically confirmed CRS, only 16%
to 20% complained of facial pain.17–19 Similarly, 75% to
97% of patients with facial pain attributed to sinus dis-
ease lacked radiographic evidence of inflammation on
CT.20–22 Many patients with facial pain may actually
have primary headache, with 88% of sinus headache suf-
ferers meeting diagnostic criteria for migraine.23 Never-
theless, neurologic sources of these symptoms may be
mistaken for CRS in the primary care setting.24,25
The 2016 ICOR guidelines require the confirmation
of symptomatic CRS with objective findings on endoscopy
or CT; however, nasal endoscopy is generally unavailable
and CT may be underutilized in the primary care setting.
In a study by Tan et al., only 50% of CRS with nasal poly-
posis (CRSwNP) and 25% of CRS without nasal polyposis
(CRSsNP) subjects underwent CT ordered by the primary
care physician (PCP); furthermore, patients were more
likely to undergo CT evaluation after initial diagnosis and
treatment.26 These data suggest that despite updated
diagnostic guidelines for CRS requiring CTor nasal endos-
copy, many PCPs rely on symptom-based diagnostic crite-
ria that may have high sensitivity but inappropriately low
specificity in predicting sinus disease.27,28
Given the frequent misattribution of facial pain and
headache to sinusitis rather than other potential underlying
etiologies, the accuracy of symptom-based clinical criteria
for CRS may improve with the elimination of pain, although
this does not appear to have been evaluated to date. In this
study, we assess the impact on diagnostic accuracy of remov-
al of facial pain and headache from clinical diagnostic crite-
ria for CRS.
MATERIALS AND METHODS
Billing records were used to identify adult patients
referred to the Department of Otolaryngology at Virginia Com-
monwealth University from November 2008 until June 2015
with a diagnosis of sinusitis. Exclusion criteria included a histo-
ry of sinonasal surgery, facial trauma, or prior sinus CT, as well
as those without subsequent CT or endoscopic evaluation.
Initial otolaryngology encounter notes were reviewed for
gender, age, previous rhinosinusitis diagnosis, prior imaging,
presenting symptoms, exam findings, medical comorbidities,
and current and past medications. Results of nasal endoscopy
and sinus CT performed within 3 months of the initial encoun-
ter were included. A subsequent diagnosis of a neurologic disor-
der such as migraine or atypical facial pain was noted.
For each patient, CRS was retrospectively diagnosed by
applying the 1997 RSTF diagnostic criteria (see Table I).15 A
modified clinical diagnostic algorithm (mRSTF) was created by
removing facial, dental, ear pain, and headache from the
symptoms (see Table I). These four symptoms were chosen for
elimination because each negatively predicted inflammation on
CT or endoscopy in our population. Radiologic presence of mucosal
disease was evaluated using the Lund-Mackay scoring system29;
scores 3 were considered indicative of sinusitis.11,30 Endoscopic
disease burden was rated using the Modified Lund-Kennedy
(MLK) scoring system,31 with scores 2 considered positive for
sinusitis.
Clinical and demographic characteristics were summarized
by descriptive statistics. Sensitivity, specificity, accuracy, posi-
tive predictive value (PPV), and negative predictive value
(NPV) were calculated for RSTF and mRSTF criteria using
either CT or endoscopy as the objective standard for sinusitis,
as per the 2016 ICOR guidelines. A binomial z-test was used to
compare RSTF and mRSTF in sensitivity, specificity, accuracy,
TABLE I.
Original and Modified 1997 Rhinosinusitis Task Force Diagnostic Criteria for CRS.
RSTF mRSTF
Major Factors Facial pain/pressure
Facial congestion/fullness
Nasal obstruction/blockage
Anosmia/hyposmia
Nasal discharge/purulence/discolored
postnasal drainage
Purulence in nasal cavity on examination
Fever (acute rhinosinusitis only)
Facial pressure
Facial congestion/fullness
Nasal obstruction/blockage
Anosmia/hyposmia
Nasal discharge/purulence/discolored
postnasal drainage
Purulence in nasal cavity on examination
Fever (acute rhinosinusitis only)
Minor Factors Headache
Fatigue
Halitosis
Cough
Dental pain
Ear pain/pressure/fullness
Fever (all nonacute)
Fatigue
Halitosis
Cough
Fever (all nonacute)
CRS 5 chronic rhinosinusitis; mRSTF 5 Modified Rhinosinusitis Task Force Criteria; RSTF 5 Rhinosinusitis Task Force Criteria.
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PPV, and NPV. Somers’ D was used to measure the concordant
rate between clinical diagnostic criteria and CT. Logistic regres-
sion was used to test association of symptoms with CT and
endoscopy scores. Forest plots via a logistic regression were
used to illustrate the associations of comorbid conditions with
diagnostic results. Significance was determined using the type
I error of 5%. Statistical analysis was performed using SAS
software version 9.4 (SAS Institute Inc., Cary, NC). This study
was reviewed and approved by the Institutional Review Board
of Virginia Commonwealth University.
RESULTS
The query of billing records identified 1,186 potential
subjects; of those, 479 (40.4%) met inclusion criteria. There
were 317 (66.2%) females and 162 (33.8%) males; with mean
age 50.3 years (standard deviation (SD)6 15.1, range 19–89).
Utilizing RSTF criteria, 349 (72.9%) met criteria for diagnosis
of CRS, versus 271 (56.6%) usingmRSTF criteria.
Among subjects, 396 (82.7%) underwent CT after ini-
tial otolaryngology evaluation, with average Lund-
Mackay score 5.1 (SD 6 5.6, range 0–24, median 3), and
203 (51.3%) with Lund-Mackay > 3, meeting criteria for
sinusitis. There were 388 (81.0%) subjects with nasal
endoscopy performed at the initial encounter, with mean
MLK score 1.6 (SD 6 2.0, range 0–10, median 1) and 179
(46.1%) with MLK > 2, meeting criteria for sinusitis.
There were 293 (61.2%) subjects who fulfilled either CT
or endoscopic criteria for sinusitis, and 101 (21.1%) who
fulfilled both CT and endoscopic criteria. Concordance
between CT and endoscopy for diagnosing sinusitis was
fair, with a Kappa coefficient of 0.302 (95% confidence
interval [CI] 0.196–0.407, P < 0.0001). The frequency of
symptoms and their associations with objective evidence
of sinusitis is presented in Table II.
Of those subjects with RSTF diagnosis of CRS, 54.8%
had CT evidence, 52.0% had endoscopic evidence, and
66.5% had either CT or endoscopic evidence of sinusitis. Of
those who met mRSTF criteria, 60.6% had CT evidence,
61.6% had endoscopic evidence, and 76.0% had either CT
or endoscopic evidence of sinusitis. The concordance
between either positive CT or endoscopy and RSTF diagno-
sis was 29.4%, with Somers’ D of 0.163 (P < 0.0001),
whereas the concordance between either CT or endoscopy
and mRSTF was 45.7%, with Somers’ D of 0.354 (P <
0.0001). Sensitivity, specificity, and accuracy of both diag-
nostic criteria were evaluated using abnormal CT, abnor-
mal endoscopy, or either abnormal CT or endoscopy as the
reference standard for diagnosis of sinusitis (see Table III).
Use of mRSTF criteria resulted in a large increase in spe-
cificity (P < 0.05) but correspondingly small, nonsignificant
trend toward decrease in sensitivity.
Comorbidities were analyzed for association with
CT or endoscopic findings. Among our subjects, 4.4% had
fibromyalgia; 6.1% had neuropathy; 11.1% had chronic
cervical pain; 14.4% had a history of migraine; 7.3% had
temporomandibular joint disorder (TMD); 18.8% had a
history of depression or anxiety; and 33.9% reported a
history of psychiatric medication use. Subjects with any
one of these comorbidities were less likely to have sinus-
itis on either CT or endoscopy (relative risk [RR] 5 0.69,
95% CI 0.578–0.828, P < 0.0001). Individually, a history
of chronic cervical pain (RR 5 0.62, 95% CI 0.442–0.872,
P 5 0.0006), TMD (RR 5 0.54, 95% CI 0.341–0.862, P 5
0.0007), depression/anxiety (RR 5 0.81, 95% CI 0.650–
1.00, P 5 0.031), and prior use of psychiatric medica-
tions (RR 5 0.85, 95% CI 0.724–1.00, P 5 0.047) were
inversely associated with the presence of sinusitis on
either CT or endoscopy (see Fig. 1).
DISCUSSION
Prior studies have shown poor correlation between
symptoms and endoscopic or radiographic evidence of
CRS.14,32 Updated 2016 ICOR diagnostic criteria empha-
sized the need for objective evidence of sinonasal inflamma-
tion to confirm the diagnosis of CRS. Whereas this
requirement is readily applicable to practicing otolaryngol-
ogists, endoscopy is not available and CTmay be underused
TABLE II.
Relationship Between Presenting Symptoms and Objective Evidence of Inflammation Using Either CT or Nasal Endoscopy as the Reference
Standard.
Symptom N
Regression
Coefficient
Standard
Error
Odds
Ratio 95% CI P Value
Facial pain 84 2.652 0.196 0.52 (0.35 to 0.77) 0.001*
Facial pressure 120 0.352 0.196 1.42 (0.97 to 2.09) 0.073
Nasal obstruction 217 1.157 0.198 3.18 (2.16 to 4.69) 0.000*
Purulent rhinorrhea 153 1.173 0.205 3.23 (2.16 to 4.83) 0.000*
Anosmia/hyposmia 74 1.278 0.294 3.59 (2.02 to 6.39) 0.000*
Headache 130 2.574 0.190 0.56 (0.39 to 0.82) 0.002*
Fatigue 32 2.282 0.282 0.75 (0.43 to 1.31) 0.319
Dental pain 14 2.759 0.369 0.47 (0.23 to 0.97) 0.040*
Ear pressure/pain 52 2.533 0.225 0.59 (0.38 to 0.91) 0.018*
Cough 66 0.374 0.241 1.45 (0.91 to 2.33) 0.121
Halitosis 15 2.153 0.409 0.86 (0.39 to 1.91) 0.709
Fever 12 0.663 0.585 1.94 (0.62 to 6.11) 0.257
*Signifies statistical significance.
CI 5 confidence interval; CT 5 computed tomography; N 5 number of subjects.
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by PCPs.26 Clinical diagnostic criteria established by the
1997 RSTF and updated in the 2016 ICOR statement both
include pain as a symptom contributing to the diagnosis of
CRS. Although facial pain or headache can indeed be due to
CRS, several studies have established that facial pain and
sinus headache are frequently migrainous or otherwise
neurologic in etiology.33–36 A reliance on symptom-based
diagnosis, as is likely the norm in the primary care setting,
may lead to frequent misattribution of neurologic facial
pain to CRS, leading to the inappropriate prescription of
antibiotics and delay in management of underlying
pathology.
The current study seeks to determine whether elim-
ination of pain-related symptoms could improve clinical
accuracy for diagnosis of CRS via symptom-based crite-
ria. The 1997 RSTF criteria were chosen for analysis
TABLE III.
Sensitivity, Specificity, Accuracy, PPV, and NPV of Clinical and Modified Clinical Diagnostic Criteria for CRS Using CT, Nasal Endoscopy,
and CT or Nasal Endoscopy as the Reference Standard.
Epidemiology Data N Sensitivity (%) Specificity (%) Accuracy (%) PPV (%) NPV (%)
CT RSTF 161 79.3 31.1 55.8 54.8 58.8
mRSTF 143 70.4 51.8 61.4 60.6 62.5
Difference 18 28.9 120.7 15.6 15.8 13.7
P value – 0.181 0.030* 0.301 0.292 0.418
Endoscopy RSTF 146 81.6 35.4 56.7 52.0 69.2
mRSTF 135 75.4 59.8 67.0 61.6 74.0
Difference 11 26.2 124.4 110.3 19.6 14.8
P value – 0.410 0.063 0.265 0.285 0.484
CT or Endoscopy RSTF 245 79.2 37.1 62.8 66.5 53.1
mRSTF 215 70.3 65.1 68.3 76.0 58.2
Difference 30 28.9 128 15.5 19.5 15.1
P value – 0.082 0.0003* 0.179 0.072 0.196
P values calculated using one-sided binomial test.
*Denotes statistical significance.
CT 5 computed tomography; mRSTF 5 Modified Rhinosinusitis Task Force Criteria; N 5 number of subjects; NPV 5 negative predictive value; PPV 5
positive predictive value; RSTF 5 Rhinosinusitis Task Force Criteria.
Fig. 1. Forest plot demonstrating impact of individual comorbid conditions on the diagnosis of rhinosinusitis using either computed tomography or
nasal endoscopy as the reference standard.
Box sizes represent the prevalence of symptoms.
*Denotes statistical significance.
LCL 5 lower confidence limit; OR 5 odds ratio; TMD 5 temporomandibular joint disease; UCL 5 upper confidence limit. [Color figure can be
viewed in the online issue, which is available at www.laryngoscope.com.]
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because these guidelines do not require objective confir-
mation of sinonasal inflammation, and thus may better
represent the diagnostic process employed by PCPs.
When applied retroactively to our cohort, mRSTF crite-
ria resulted in a significant increase in specificity with-
out a concordant loss of sensitivity in the diagnosis of
CRS. There was an upward trend in overall diagnostic
accuracy for mRSTF criteria, regardless of whether CT,
endoscopy, or either CT or endoscopy were used as the
reference standard for sinonasal inflammation.
Applying traditional RSTF criteria to our data dem-
onstrated a PPV of 54.8% for abnormal CT, similar to
published data.10 This low PPV portends frequent false-
positive clinical diagnoses of sinusitis, supporting the
notion that symptom-based diagnostic criteria are poorly
suited to differentiating CRS from other diseases that
may manifest similar symptoms.37–39 Use of mRSTF
criteria led to no statistical change in PPV or NPV,
although both trended higher. Despite more stringent
criteria, the reduction of false positive diagnoses seen
with the elimination of headache and pain from the
mRSTF criteria did not result in a significant loss of sen-
sitivity or NPV within our study population.
Prior studies have demonstrated that nasal obstruc-
tion,40–43 postnasal drip,42 purulent rhinorrhea,41,43 and
smell disturbances42–45 are associated with the presence
of sinonasal inflammation. Likewise, the current study
demonstrated that subjects with purulent rhinorrhea,
nasal obstruction, and anosmia were more likely to have
abnormal CT or endoscopy, and that patients with head-
ache, facial, dental, and ear pain were more likely to
have normal radiographic or endoscopy.
Comorbidities characterized by chronic head and
neck pain, particularly cervical pain and TMD, negative-
ly predicted the presence of sinusitis on CT or endoscopy
within this study population. Migraines and fibromyal-
gia both narrowly missed statistical significance as nega-
tive predictors of sinus disease. Additionally, patients
with a history of depression/anxiety and psychiatric
medication use were less likely to have objection inflam-
mation. These findings suggest that subjects with comor-
bidities characterized by chronic head and neck pain or
depression/anxiety may have lower pretest probabilities
of CRS, and thus benefit from earlier CT and neurologic
evaluation, rather than trials of extended antimicrobial
therapy. Prior work by Tan et al. supports the notion
that upfront CT may be advantageous over empiric anti-
biotic therapy in the primary care setting.46–48
Rhinosinusitis is a highly prevalent disease result-
ing in considerable personal and societal costs.1,3–6
Although 20 million diagnoses of sinusitis are made in
the United States annually, a growing body of research
indicates that accurate diagnosis of sinusitis, especially
using symptom-based criteria, is problematic. Use of
objective modalities such as CT or nasal endoscopy may
improve diagnostic accuracy, but are underused or
unavailable in the primary care setting where many ini-
tial diagnoses of CRS are made. Moreover, upfront CT
has been suggested to be more cost-efficient in most cir-
cumstances when compared to empiric antibiosis,46,47
but if overused may produce an unacceptable increase in
the incidental finding of mucosal thickening and unnec-
essary treatment of presumed sinusitis.49 An improved
ability to parse out symptomatic sinonasal inflammation
is critical in optimizing diagnosis of CRS. In this study,
the elimination of headache, ear, dental, and facial pain
from clinical criteria significantly improved specificity
without sacrificing sensitivity, and may be applicable to
a broader population undergoing evaluation by PCPs for
possible CRS.
This study is limited by selection bias, in that our
population consisted of patients with suspected CRS
referred to an academic otolaryngology practice. The
presence of a comparison group without symptoms of
CRS would help control for confounding variables and
demonstrate baseline characteristics in a healthy popu-
lation. Additionally, the retrospective design and lack of
standardized questionnaires or endoscopic rating sys-
tems may have reduced the reliability of data extracted
from the study population. Broad, poorly defined symp-
toms such as pain may be particularly difficult to opera-
tionalize when performing a retrospective review.50 In
the absence of a structured method for querying symp-
toms, patients might focus on more tangible symptoms
of CRS, such as obstruction or drainage, leading to an
underrepresentation of facial pain/pressure in partici-
pants with legitimate inflammatory disease.
Gender is another potential source of bias because
women constituted 66.2% of the study population and
are more likely to report facial pain and headache.51 Lal
et al demonstrated that women presented with higher
Sino-Nasal Outcome Test 22 and lower Lund-Mackay
scores than men,52 indicating a tendency to report more
severe sinonasal symptoms despite lesser objective evi-
dence of inflammation. An over-representation of women
within this cohort could result in a misleadingly low spe-
cificity for diagnostic criteria. However, gender subgroup
analysis showed minimal effect. For the entire cohort,
using abnormal CT or endoscopy as the reference stan-
dard, the specificity and sensitivity of the mRSTF crite-
ria were 65.1% and 70.3%, respectively, whereas these
changed to 68.2% and 67.8% for male subjects, and to
64.1% and 72.0% for female subjects, respectively.
This study was designed to assess diagnostic accu-
racy for CRS using clinical criteria in previously undiag-
nosed patients, as may frequently present to PCPs.
Patients with a history of sinonasal surgery were exclud-
ed because one might reasonably expect that a positive
CT or endoscopy led to prior surgical intervention.
Excluding patients with previous surgery could bias the
population to less significant disease, impacting sensitiv-
ity or specificity calculations. Additionally, the predictive
value of pain for true inflammatory disease could poten-
tially differ in the postoperative population.
Not all study participants had both CT and nasal
endoscopy performed. Given the imperfect concordance
between these modalities found among subjects who
underwent both procedures, it is possible that patients
with only a negative CT or endoscopy were considered
not to have sinusitis; although if performed, a second
test may have been positive. This would result in an
inappropriately low estimation of sensitivity within the
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study population; however, we would expect that this
effect would alter specificity and sensitivity calculations
for both RSTF and mRSTF diagnostic criteria in parallel
fashion, and thus not likely impact the nature of our
conclusions. Future prospective studies could employ
validated questionnaires and endoscopy-scoring systems
to verify whether the trends identified in this retrospec-
tive cohort can be generalized to a greater population
with presumed CRS.
CONCLUSION
The elimination of facial pain, dental pain, ear
pain, and headache from clinical diagnostic criteria for
CRS resulted in significantly improved specificity for
diagnosis of sinusitis as confirmed via CT or nasal
endoscopy. Ongoing research is necessary to optimize
diagnostic algorithms for CRS, particularly in the prima-
ry care setting, which may in turn lead to decreased
inappropriate antibiotic use and delay in management of
primary headache syndromes.
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